Literature DB >> 20143464

MicroRNA155 is induced in activated CD4(+) T cells of TNBS-induced colitis in mice.

Da-Fan Chen1, Bang-Dong Gong, Qing Xie, Qi-Wen Ben, Jun Liu, Yao-Zong Yuan.   

Abstract

AIM: To investigate the expression of microRNA155 (miRNA155) in trinitrobenzene sulphonic acid (TNBS)-induced colitis and the relationship between miRNA155 and tumor necrosis factor (TNF) expressions.
METHODS: In TNBS colitis mice, miRNA155 and TNF mRNA expressions were measured in colons and CD4(+) T cells of draining lymph nodes (LNs). CD4(+) T cells were cultured in vitro with or without anti-CD3/CD28 antibody, and the expressions of miRNA155 and TNF mRNA in cells and TNF concentration in culture media were examined.
RESULTS: miRNA155 and TNF mRNA expressions in colons and in cells of LNs were significantly increased in TNBS colitis compared with controls. In TNBS colitis, miRNA155 and TNF mRNA expressions in CD4(+) T cells of LNs and TNF concentration in CD4(+) T cells culture media increased compared with controls. When cultured with anti-CD3/CD28 antibody, miRNA155 and TNF mRNA expressions in CD4(+) T cells and TNF concentration in the CD4(+) T cells culture media were significantly higher than those cultured without anti-CD3/CD28 antibody. Following analysis using the Pearson's correlation coefficient, miRNA155 expression had a significant positive correlation with either TNF mRNA expression in CD4(+) T cells (r = 0.860, P < 0.05) or TNF concentration in CD4(+) T cells culture media (r = 0.892, P < 0.05).
CONCLUSION: miRNA155 is induced in colons and activated CD4(+) T cells in TNBS colitis, and the levels of miRNA155 and TNF expressions have a significant positive correlation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143464      PMCID: PMC2825332          DOI: 10.3748/wjg.v16.i7.854

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA.

Authors:  W Tam
Journal:  Gene       Date:  2001-08-22       Impact factor: 3.688

Review 2.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

Review 3.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 4.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

5.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs.

Authors:  Rui Yi; Yi Qin; Ian G Macara; Bryan R Cullen
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

Review 6.  Immune networks in animal models of inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi; Atul K Bhan
Journal:  Inflamm Bowel Dis       Date:  2003-07       Impact factor: 5.325

7.  Hapten-induced model of chronic inflammation and ulceration in the rat colon.

Authors:  G P Morris; P L Beck; M S Herridge; W T Depew; M R Szewczuk; J L Wallace
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

Review 8.  Immune mechanisms in chronic inflammatory bowel disease.

Authors:  C P Braegger; T T MacDonald
Journal:  Ann Allergy       Date:  1994-02

9.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Authors:  Yuanjia Tang; Xiaobing Luo; Huijuan Cui; Xuming Ni; Min Yuan; Yanzhi Guo; Xinfang Huang; Haibo Zhou; Niek de Vries; Paul Peter Tak; Shunle Chen; Nan Shen
Journal:  Arthritis Rheum       Date:  2009-04

10.  A requirement for CARMA1 in TCR-induced NF-kappa B activation.

Authors:  Donghai Wang; Yun You; Sara M Case; Linda M McAllister-Lucas; Lin Wang; Peter S DiStefano; Gabriel Nuñez; John Bertin; Xin Lin
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

View more
  6 in total

1.  Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model.

Authors:  Krishnan MohanKumar; Niroop Kaza; Ramasamy Jagadeeswaran; Steven A Garzon; Anchal Bansal; Ashish R Kurundkar; Kopperuncholan Namachivayam; Juan I Remon; C Rekha Bandepalli; Xu Feng; Joern-Hendrik Weitkamp; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-26       Impact factor: 4.052

Review 2.  MicroRNA-155 as a therapeutic target for inflammatory diseases.

Authors:  Naghmana Kanwal; Peter John; Attya Bhatti
Journal:  Rheumatol Int       Date:  2012-12-14       Impact factor: 2.631

3.  mir-155 regulates cardiac allograft rejection by targing the expression of suppressor of cytokine signaling-1 (DOCS1) in dendritic cells.

Authors:  Yi Gao; Fang Liu; Qiwei Zhou; Meng Guo; Mingjian Zhang; Wenyuan Guo; Liming Wang; Liping Hu; Chaozhou Hu; Yongzhao Shi; Yushan Liu; Quanxing Wang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Resveratrol Downregulates miR-31 to Promote T Regulatory Cells during Prevention of TNBS-Induced Colitis.

Authors:  Haider Rasheed Alrafas; Philip B Busbee; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Mol Nutr Food Res       Date:  2019-12-11       Impact factor: 5.914

5.  MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression.

Authors:  Ruozhen Hu; Thomas B Huffaker; Dominique A Kagele; Marah C Runtsch; Erin Bake; Aadel A Chaudhuri; June L Round; Ryan M O'Connell
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

6.  miR-802 participates in the inflammatory process of inflammatory bowel disease by suppressing SOCS5.

Authors:  Jun Yao; Ruoyu Gao; Minghan Luo; Defeng Li; Liliangzi Guo; Zichao Yu; Feng Xiong; Cheng Wei; Benhua Wu; Zhenglei Xu; Dingguo Zhang; Jianyao Wang; Lisheng Wang
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.